Astra's Farxiga results may open up type 1 diabetes opportunity
IN -

FRANKFURT (Reuters) - AstraZeneca's Farxiga was shown to help type-1 diabetics when added to standard insulin therapy, possibly opening up a additional market opportunity for the type-2 diabetes drug, the British drugmaker said in a statement on Thursday.

Loading...

Related Articles